Minneman CV

Kenneth Paul Minneman, Ph.D. Page 1
Curriculum Vitae
KENNETH PAUL MINNEMAN
Personal
Born: Sacramento, California, September 1, 1952
Children: Jennifer, 1983; Rebecca, 1985; Jeffrey, 1988
Social Security No.: 508-68-7148
Home: 222 14th
Street, Apt 515, Atlanta, GA
Education
Ph.D. University of Cambridge, England; Pharmacology, 1977
B.S. Massachusetts Institute of Technology; Life Sciences, 1974
Employment
Founding Dean, Division of Chemical and Life Sciences and Engineering, KAUST, 2009-2012
Named Professor of Bioscience, KAUST, 2009-2012
Emeritus Professor, Emory University, 2009-present
Charles Howard Candler Professor of Pharmacology, Emory University, 2000-2009
Professor, Department of Pharmacology, Emory University, 1990-2000
Associate Professor, Department of of Pharmacology, Emory University, 1985-2000
Assistant Professor, Department of Pharmacology, Emory University, 1980-1985
Research Associate in Pharmacology, University of Colorado Medical Center, 1977-1980
Honors and Awards
President, American Society for Pharmacology and Experimental Therapeutics, 2007-2008
Executive Board, Federation of American Societies for Experimental Biology, 2007-2010
Leading Scientists of the World 2006, International Biographical Center, Cambridge, England, 2006
Who’s Who in Medical Science Education, Academic Keys, 2005-present
Woodruff Leadership Academy, Emory University, 2005
Keynote Speaker, Basic Research in Undergraduate Institutions, Grand Island, NE, 2005
Chair: Division for Molecular Pharmacology, ASPET, 2004-2005
Dean’s Teaching Award for Medical Students, Emory University, 2003
ISI Highly Cited Researcher, Pharmacology 1981-1999, Institute for Scientific Information, 2002
Delegate, International Union of Pharmacology Meeting, San Francisco, CA 2002
Teaching Excellence Award, Dept. of Pharmacology, Emory University, 2001, 2007
Charles Howard Candler Professor of Pharmacology, Emory University, 2000-present
PhRMA Award for Basic Science Career Excellence, Pharmaceutical Research and Manufacturing Assn., 2000
Marquis Who’s Who, 2000-present
Executive Council, American Society for Pharmacology and Experimental Therapeutics, 1999-2002
Distinguished Lecturer, Creighton University Medical School, 1999
China Medical Board Forum Distinguished Lecturer, Beijing Medical University, 1999
Keynote Speaker, Mercer University Day of Science, 1992
John Jacob Abel Award, American Society for Pharmacology and Experimental Therapeutics, 1989
Faculty Development Award, Pharmaceutical Manufacturers Association Foundation, 1981-1983
Individual Postdoctoral Fellowship, Public Health Service, 1978-1980
National Needs Postdoctoral Fellowship, National Science Foundation, 1977-1978
Graduate Fellowship, National Science Foundation, 1974-1977
Administrative Appointments
Dean, Division of Chemical and Life Sciences and Engineering, KAUST, 2009-Present
Course Director, General Medical Pharmacology, 1997-2007
Director, Graduate Program in Molecular Therapeutics and Toxicology, 1996-1999
Director, Graduate Program in Physiological and Pharmacological Sciences, 1988-1991
Director, Graduate Studies, Dept. of Pharmacology, 1988-1992

Professional Societies
American Society for Pharmacology and Experimental Therapeutics
American Association for the Advancement of Science
Editorial Appointments
Associate Editor, Molecular Pharmacology, 1995-2000
Associate Editor, Journal of Pharmacology and Experimental Therapeutics, 1998-2000
Field Editor, Autonomic Pharmacology, Journal of Pharmacology and Experimental Therapeutics, 1992-1997
Associate Editor, Pharmacology Reviews and Communications, 1991-present
Editor, Brody’s Human Pharmacology: Molecular to Clinical. Mosby/Elsevier Co., 2nd
edition (1994), 3rd
edition
(1998), 4th
edition (2005).
Editor, Current Opinion in Pharmacology, 2008-2009
Editorial Advisory Boards
Faculty of 1000, 2006-2012
Synapse, 2004-2009
Molecular Interventions, 2000-20009
Acta Pharmacologica Sinica, 1999-2009
The Pharmacologist, 1999-2002
European Journal of Pharmacology, 1992-2009
Receptors and Signal Transduction, 1990-2001
Journal of Neurochemistry, 1989-1997
Blood Vessels, 1987-1991
Molecular Pharmacology, 1983-1995
Advisory Committees
Torald Sollmann Award Selection Committee, ASPET, 2002-2006
NIH Pharmacology Study Section, 1996-2000
Chairman, John Jacob Abel Award Selection Committee, ASPET, 1996-1997
Molecular Signaling Study Committee, American Heart Association, 1993-1997; Chairman 1995-1997
Nominating Committee, American Society for Pharmacology and Experimental Therapeutics, 1994-1995
IUPHAR Subcommittee for Drug Classification and Receptor Nomenclature for the Adrenoreceptors, 1992-2005
NIH Cardiovascular and Renal Study Section, 1989-1993
Parent Review Committee NHLBI Specialized Centers of Research in Coronary and Vascular Diseases, and Heart
Failure 1988-1989
Advisory Committees (Ad hoc)
NIH Study Sections: Vascular Biology Study Section, (10/06); NIGMS PRAT Fellow Review Committee (3/03);
Special Toxicology (10/94); Pharmacology (10/94); Special Cardiovascular Sciences (11/92); Chairman, Special
Cardiovascular and Renal (11/90); Special Toxicology II (6/92); Special Endocrinology (8/90); NIH Cardiovascular
and Renal (3/87); (6/88)
American Heart Association Molecular Signaling I (10/05)
National Heart, Lung, and Blood Institute SCOR Site Visits (12/88); (1/89; Chair); (1/89)
Board of Scientific Counselors, National Institute on Aging (5/86)
Veteran’s Administration Merit Review Board for Basic Sciences (10/84);
National Institute for Neurological and Communicable Diseases Program Project Site Visits (5/81); (5/83)
Special Review Committee, National Institute on Drug Abuse (6/81)
Teaching Experience
Cell Biology: Graduate Students, 2009-2012
Pharmacology: Graduate, Medical, and Physician Associate Students, 1980-2009
Course Director, “General Medical Pharmacology” 1997-2009; Dental and
Nursing Students, 1980-1987
Neurobiology: Graduate and Medical Students, 1983-1991
Graduate Courses: "Prostaglandins, Thromboxanes and Leukotrienes", 1982

"Cell Surface Receptors", 1982,1985,1988,1990,1992,1994,1996-1999,2001,2003
“Neuropharmacology” 1992, 1995, 1998; "Mechanisms and Therapeutics of Cardiovascular
Disease" 1994; Molecular Endocrinology" 1995, “Cellular Neuroscience” 1996-1999,
“Receptors” 1093-2008
Emory University Committees
Faculty Senate, Emory University, 2005-2008
Faculty Council, Emory University, 2005-2008
Woodruff Health Sciences Library Advisory Committee, 2005-2008
Co-Chair Curriculum Revision Subcommittee “Translation of Medical Sciences”, 2005
Admissions Committee, Medical School, 2002-2008
Faculty Council, Emory University, 2002-2005
Implementation Committee, Strategic Plan for Teaching and Education, Medical School, 1999-2002
University Research Committee, 1998-2001; Chair, Biological Sciences Subcommittee, 1999-2001
Appointments & Promotions Committee, Medical School, 1992-1995; 1999-2001
Objectives Committee for LCME Accreditation Site Visit, 1998-1999
Educational Program Leading to MD Degree Committee for LCME Accreditation Site Visit, 1998-1999
Executive Curriculum Committee, Medical School, 1998-2003
Strategic Planning Committee on Teaching and Education, Steering Committee, Medical School, 1998
Strategic Planning Committee on Research, Basic Science Subcommittee, Medical School, 1998
Chairman, Executive Committee, Program in Molecular Therapeutics and Toxicology, 1996-1999
Progress and Promotions Committee, M2, Medical School, 1997-present
Admissions Committee, Neuroscience Graduate Program, 1995-1996
Curriculum Committee, Neuroscience Graduate Program, 1994-1995
Search Committee for Associate Dean for Research, Medical School, 1992
Chairman, Executive Committee, Program in Physiological and Pharmacological Sciences, 1989-1991
Chairman, Special Faculty Relations Committee, Medical School, 1990
Literacy in Science Subcommittee of Education Committee, Medical School, 1989-1991
Search Committee, Chair of Molecular and Human Genetics, 1989-1990
Executive Committee, Graduate School of Arts and Sciences, 1988-1990
Faculty Relations Committee, Medical School, 1986-1989; 2000-2004; Chairman, 1989; 2003
Hines Lectureship Committee, 1985-1990
Co-Chairman, Organizing Committee, Program in Physiological and Pharmacological Sciences, 1988
Appointments and Promotions Committee, Medical School, 1986-1988
Executive Committee, Neurosciences Training Program, 1985-1988
Graduate Neurobiology Curriculum Committee, 1984-1985
Search Committee, Woodruff Professor of Neuroscience, 1981-1983
Medical Neurobiology Curriculum Committee, 1981-1982
KAUST Committees
Provost Search Committee, 2009-2011
President’s Advisory Council, 2009-2012
Senior Leadership Team, 2009-2012
Academic Leadership Team, 2009-2012
Web Advisory Committee, 2009-2012
Appointments and Promotions Committee, 2009-2012
Faculty Recruiting Committee (Bioscience, Marine Science, Chemistry, Chemical and Biological Engineering,
Environmental Science and Engineering), 2009-2012
University Research Committee, 2009-2012
Faculty Council, 2009-2012
Curriculum Committee, 2009-2012
Provost Advisory Committee, 2009-2012
Program Committee for Biosciences (Chair), 2009-2012
Admissions Committee (Bioscience), 2009-2012
Space Allocation Committee, 2010-2012
Dean’s Search Committee, 2011-2012

Chairman, Biosafety and Ethics Committee, 2011-2012
Emory University Ph.D. Thesis Committees
Laura Uphouse, Scott Turner, Bruce Appelbaum, Kenneth Locke, Ira Finn, Christina Leone, Geoffrey Mumford, Jill
Adams, Brian Donohue, Jeff Boatright, Manisha Desai, Carol Paronis (Pharmacology), Al Rauch (Pathology), Frank Sabatini
(Anatomy), Laura Tang (Physiology), Yan-Hua Chen (Anatomy), John Vanchierre (Neuroscience), Aurora Isaac
(Neuroscience), Danny Winder (Neuroscience), Hennessey Tsien (Physiological and Pharmacological Sciences), Bridgette
Garrett (Physiological and Pharmacological Sciences), Robert Gerau (Neuroscience), Dorothy Chung (Neuroscience), Jennifer
Duff (Biochemistry and Molecular Biology), Bill Paxton (Physiological and Pharmacological Sciences), Susan Rouse
(Neuroscience), Joe Blumer (Microbiology & Molecular Genetics), Lani Paxton (Physiological and Pharmacological
Sciences), Michael LaFlamme (Molecular Therapeutics and Toxicology), Ernesto Ince (Neuroscience), Alison Ogonowski
(Mercer Univ Pharmacy School), Hongzhu Yang (Cell and Molecular Biology), Jennifer Berkeley (Neuroscience); Rick
Peavey (Molecular Therapeutics and Toxicology);Romesh Subramanian (Molecular Therapeutics and Toxicology), Laura
Volpicelli (Neuroscience), Erin Hoag (Molecular and Systems Pharmacology), Sara Wirtz (Chemistry), Vidya
Balasubramanian (Molecular and Systems Pharmacology), Jim Nettles (Molecular and Systems Pharmacology), Michelle
Bellini (Molecular and Systems Pharmacology), Cristina Bush (Molecular and Systems Pharmacology), Christine Griffin
(Biochemistry, Cell and Developmental Biology), Gus Davis (Neuroscience)
External Activities
External Examiner, Ph.D. thesis in Pharmacology, New York University, 1985, University of Melbourne, 1988
Guest Faculty, Graduate Course in Receptor Mechanisms, Mercer Univ. Pharmacy School, 1989, 1991, 1993
Guest Faculty, Graduate Course in Autonomic Pharmacology, Medical College of Wisconsin, 1989
Visiting Professor, Universidad de Santiago de Chile, Departamento de Farmacologia, 1991, 1993, 1996
Visiting Professor, Università di Catania, Italy; Department of Pharmaceutical Sciences, Catania, 2003
Visiting Professor, American University of the Caribbean, St. Maarten’s, West Indies, 2006
Predoctoral Trainees
John M. May, Ph.D. (1985) "Characterization and Regulation of β2-Adrenergic Receptors in Rat Vas Deferens."
PMAF predoctoral fellowship 1984-1985.
Ronald D. Johnson, Ph.D. (1986) (M.D., Uniformed Services Univ., 1990) "α1-Adrenergic Receptors in Rat Brain."
PMAF predoctoral fellowship 1985-1986.
Ali Nasseri, Ph.D. (1987 ) (M.D. Univ. of Maryland, 1991) "Characterization of α2-Adrenergic Receptors in Rat
Cerebral Cortex."
Carl W. Bazil, M.D., Ph.D.(1988) "Volatile Anesthetics and Synaptic Neurochemistry." NIMH individual
predoctoral fellowship (MH 09525) 1986-1988.
Saakwa Mante, M.D., M.S. (1991) "Caffeine and adenosine receptors in rat cerebral cortex."
Brian Atkinson, Ph.D. (1992) "Adrenergic receptor subtypes mediating second messenger responses to norepinephrine
in rat brain." Currently Research Pharmacologist, Trophix Pharmaceuticals.
Rockey Bandlish, M.S. (1993) Coexisting β-adrenergic receptor subtypes in SKNMC cells.
Hong-ying Zhong, Ph.D. (1995) “Interactions between coexisting β-adrenergic receptor subtypes in C6 glioma cells”
Tracey Theroux, Ph.D (1996). “α1-Adrenergic receptor subtypes and signal transduction”.
Shelley Wood Guerrero, Ph.D. (1997) NIDA individual predoctoral fellowship, 1994-1995, PMAF predoctoral
fellowhship 1995-1996.
Zhongjian Chen (2001-2006)
Postdoctoral Trainees/Visiting Faculty
Anthony W. Fox, M.D. (Univ. London), 1981-1982; 1983-1984; Recipient of Rotary Foundation Fellowship,
Chide Han, M.D. (Beijing Univ.), 1986-1987, 1989-2004; Biotechnology Career Development Award, Rockefeller
Foundation (1989-1994),
Karen Wilson, Ph.D. (Univ. Florida), 1987-1989.
Lori Katz, Ph.D. (Boston Univ.), 1990-1991.
Timothy Esbenshade, Ph.D. (Ohio State Univ.), 1991-1996. NRSA postdoctoral fellowship (1990-1993).
Nidhi G. Williams, Ph.D. (Harvard Univ.), 1994-1996. NRSA fellowship (1994-1996).
Hongying Zhong, Ph.D. (Emory), 1996-1999.

Alf Berts, Ph.D. (Univ. Uppsala), 1997-1999.
Aleksandra Vicentic, Ph.D. (Loyola), 1999-2001.
Michelle Uberti, Ph.D. (University of the Sciences), 2000-2003.
Andre Sampaio Pupo, Ph.D (University of Botucatu, Brazil), 2000-2002.
Rebecca Wright, Ph.D. (East Carolina Univ.) 2001-2003.
Chris Hague, Ph.D. (Creighton University) 2002-2005.
Undergraduate Students
Edward Stein, B.S. (1988) Undergraduate research 1986-1987.
Robert Levy, B.S. (1988) Undergraduate research 1987-1988; With highest honors.
Shahzad Mian, Undergraduate research 1990, 1991 (Howard Hughes fellowship)
Doug Landsman, B.S. (1991) Undergraduate research 1990-1991.
Shawn Dennison (B.S., Lee College 1993), Undergraduate research 1991.
Tracey Theroux (B.S. Syracuse Univ. 1991), Undergraduate Research, 1991.
Suzanne Hollinger, B.S. (1993), Undergraduate research 1992-1993.
Erem Sheikh, B.S. (1993), Undergraduate research 1992.
Kathi Dantley (Hampton College), Undergraduate research 1993.
Kavitha Kosuri, B.S., Undergraduate research 1995, 1996.
Charles Gunawan, B.S. (2000) Undergraduate research 2000, 2001.
Invited Lectures at National and International Meetings
Pharmacology of Adrenoceptors, Beijing, China, Organizer, July 2006
International Society for Pathophysiology, Beijing, China, July 2006
Perry B. Molinoff Symposium, Univ. Pennsylvania School of Medicine, Philadelphia, PA, May 2005
Great Lakes G Protein Coupled Receptor Retreat, Bromont, Canada, November, 2004
XXXVI Brazilian Society of Pharmacology, Aguas de Lindoia, Brazil, October 2004
American Society of Hypertension Laragh Conference, Miami, FL, January 2003
Pharmacology of Adrenoceptors, Sonoma Valley, CA, July 2002
Pharmaceuticals in Source and Drinking Water, CDC, Atlanta, GA, October 2001
3rd
Intl. Symposium on Membrane Receptors, Signal Transduction and Drug Action, Yokohama, Japan, 2000
European Journal of Pharmacology Spring Symposium, Zeist, The Netherlands. 1999
International Symposium on Pharmacological Receptors, Santiago, Chile, 1996
Co-Organizer, International Symposium on Cardiovascular Adrenoceptors, Beijing, China, 1995
Camerino-Noordwijkerhout Symposium, Camerino, Italy, 1995
Tamsulosin and α1-Adrenoceptor Subtypes, The Hague, The Netherlands, 1995
Pharmacology of Adrenoceptors, Philadelphia, PA, 1994
Postgraduate Course on Receptors and Signalling, Santiago, Chile, 1993
Symposium on the Preclinical Pharmacology of Tamsulosin, Amsterdam, The Netherlands, 1993
Biochemical Society Symposium, Sheffield, England, 1993
Urology Advisory Council, Abbott Laboratories, Chicago, IL, 1993
Organizer, ASPET Symposium on α1-Adrenergic Receptor Subtypes, Orlando, Florida, 1992
Smooth Muscle International Symposium, Fukuoka, Japan, 1992
Course on Receptors and Signal Transduction, Santiago, Chile, 1991
American Physiological Society, San Antonio, Texas, 1991
Adrenoceptor Symposium, Manchester, England, 1990
FASEB Thematic Symposium, Washington, D.C., 1990
Southeastern Pharmacological Society, Augusta, Georgia, 1989
American Society for Neurochemistry, New Orleans, Louisiana, 1988
Sixth International Catecholamine Symposium, Jerusalem, Israel, 1987
European Society for Neurochemistry, Prague, Czechoslovakia, 1986
ASPET Symposium on Alternate Second Messengers, Baltimore, Maryland, 1986
Smooth Muscle Function Symposium, Banff, Alberta, 1986
"Scholar-in-Residence," Addiction Research Center, Lexington, Kentucky, 1983
Symposium on Receptors and Chronic Obstructive Lung Disease, Dutch Asthma Society, Utrecht, Holland, 1982
Neuroreceptor Symposium at Indiana State University, Terre Haute, 1982

Symposium on Molecular Biology of Neurotransmitter Receptors, Hiroshima, Japan, 1981
Gordon Conference on Cyclic Nucleotides, New Hampshire, 1979
NATO Advanced Study Institute on Cyclic Nucleotides, Tremezzo, Italy, 1977
Invited Seminars (Not at Emory)
2009 King Abdullah University of Science and Technology (KAUST), Saudi Arabia
2008 Kuwait University Medical School, Kuwait City; Michigan State University
2007 University of Illinois, Chicago, IL
2006 Abbott Laboratories; Chicago, IL
2005 University of Pennsylvania, University of Nebraska Medical Center
2004 University of Botucatu, Brazil; University of Sao Paolo, Brazil
2003 University of Catania, Sicily; Cephalon, Inc.
2002 University of Connecticut Medical Center
2001- Centers for Disease Control and Prevention, Emory University Department of Pathology
2000- Medical College of Georgia
1999- National Institute on Aging, University of Houston, Beijing University Medical Center, Creighton University,
Medical College of Georgia
1998- Bristol-Myers Squibb, University of Colorado Medical Center
1997- Ohio State University
1996- University of West Virginia, R.W. Johnson Pharmaceutical Research Institute, University of Tennesse,
Memphis
1995- Yamanouchi Europe, George Washington University
1994 - University of Pennsylvania
1993 - Glaxo, Abbott Laboratories, University of Essen Medical School, Germany
1992 - Beijing Medical University, China, Abbott Laboratories, Synaptic Pharmaceutical Co., Uniformed Services
University Health Science Center
1991 - Syntex Inc., Universidad de Santiago de Chile, Univ. Texas Hlth. Sci. Ctr. San Antonio
1990 - Cleveland Clinic; Case Western Reserve University; Procter and Gamble Company; Merck, Sharpe & Dohme
(England); Abbott Laboratories; University of Georgia School of Pharmacy; GLAXO, Inc.
1989 - University of Missouri Medical School; Eli Lilly Company; Smith, Kline & Beecham Laboratories; Medical
College of Wisconsin; Cornell University; Brown University; Procter and Gamble Company
1988 - University of South Carolina Medical School
1987 - University of Florida Medical School; University of Tennessee Medical School
1986 - Burroughs-Wellcome; FIDIA - Georgetown Institute for Neuroscience
1985 - University of Pennsylvania; University of South Alabama; University of North Carolina
1984 - Mt. Sinai Medical School
Consultancy Agreements
Procter and Gamble, 1990-1992
Glaxo, Inc., 1991-1993
Abbott Laboratories, 1991-1992
Syntex, Inc., 1991-1992
Yamanouchi Europe, 1993-1997
R.W. Johnson Pharmaceutical Research Institute, 1996-2001
Coca-Cola Company, 2001-2009

PUBLICATIONS (Total citations 11,909; h-factor 53 according to Google Scholar)
Articles:
1. Minneman, K.P., Lynch, H.J. and Wurtman, R.J. (1974) Relationship between environmental light intensity and retina-
mediated suppression of rat pineal Serotonin-N-Acetyl-Transferase activity. Life Sciences 15: 1791-96.
2. Minneman, K.P. and Wurtman, R.J. (1975) Effects of pineal compounds on mammals. Life Sciences 17: 1189-1200.
3. Minneman, K.P. and Iversen, L.L. (1976) Cholera toxin induces pineal enzymes in culture. Science 192:803-805.
4. Minneman, K.P. and Iversen, L.L. (1976) Diurnal rhythm in rat pineal cyclic nucleotide phosphodiesterase activity.
Nature 260: 59-61.
5. Minneman, K.P. (1976) Cyclic nucleotide phosphodiesterase in rat neostriatum: properties of the enzyme in crude
homogenates. J. Neurochem. 27: 1173-1180.
6. Minneman, K.P. (1976) Cyclic nucleotide phosphodiesterase in rat neostriatum: multiple isoelectric forms with similar
kinetic properties. J. Neurochem. 27: 1181-1189.
7. Minneman, K.P. and Wurtman, R.J. (1976) The pharmacology of the pineal gland. Annual Review of Pharmacology
16: 33-51.
8. Kelly, P.H., Joyce, E.M., Minneman, K.P. and Phillipson, O.T. (1977) Biochemical evidence concerning the specificity
of intracerebral 6-hydroxydopamine injections. Brain Research 122: 382-387.
9. Minneman, K.P. and Iversen, L.L. (1977) Enkephalin and opiate narcotics increase cyclic GMP accumulation in slices
of rat neostriatum. Nature 262: 313-314.
10. Smith, J.A., Padwick, D., Mee, T.J., Minneman, K.P. and Bird, E.D. (1977) Synchronous nyctohemeral rhythms in
human blood melatonin and human post-mortem pineal enzymes. Clinical Endocrinology 6: 219-225.
11. Minneman, K.P. (1977) Postsynaptic induction of serotonin-N-acetyl-transferase and the control of cyclic nucleotide
metabolism in organ cultures of the rat pineal. Mol. Pharmacol. 13: 735-744.
12. Minneman, K.P., Quik, M. and Emson, P.C. (1978) Receptor-linked cyclic AMP systems in rat neostriatum:
differential localization revealed by kainic acid injection. Brain Research 151: 507-521.
13. Minneman, K.P., Quik, M. and Emson, P.C. (1978) Possible glial localization of specific receptor linked cyclic AMP
systems in rat striatum: studies with kainic acid. In "Mol. Biol. and Pharmacol. of Cyclic Nucleotides" ed. G. Folco
and R. Paoletti, Elsevier, Amsterdam, 207-222.
14. Minneman, K.P. and Cuello, A.C. (1979) Cyclic nucleotide phosphodiesterase localization in nerve terminals of the rat
substantia nigra. J. Neurochem. 33: 587-591.
15. Minneman, K.P., Dibner, M.D., Wolfe, B.B. and Molinoff, P.B. (1979) β1- and β2-Adrenergic receptors in rat cerebral
cortex are independently regulated. Science 204: 866-868.
16. Minneman, K.P., Hegstrand, L.R. and Molinoff, P.B. (1979) The pharmacological specificity of β1- and β2-adrenergic
receptors in rat heart and lung in vitro. Mol. Pharmacol. 16: 21-33.
17. Minneman, K.P., Hegstrand, L.R. and Molinoff, P.B. (1979) Simultaneous determination of β1- and β2-adrenergic
receptors in tissues containing both receptor subtypes. Mol. Pharmacol. 16: 34-46.
18. Hegstrand, L.R., Minneman, K.P. and Molinoff, P.B. (1979) Multiple effects of guanosine 5'triphosphate on β-
adrenergic receptors and adenylate cyclase in rat heart, lung and brain. J. Pharm. Exp. Ther. 20: 215-221.
19. Zahniser, N.R.,Minneman, K.P. and Molinoff, P.B. (1979) Persistence of β-adrenergic receptors in rat striatum
following kainic acid administration. Brain Research 178: 589-595.
20. Sinensky, M., Minneman, K.P. and Molinoff, P.B. (1979) Increased membrane acyl chain ordering activates adenylate
cyclase. J. Biol. Chem. 254: 9135-9141.
21. Minneman, K.P., Hedberg, A. and Molinoff, P.B. (1979) Comparison of β-adrenergic receptor subtypes in mammalian
tissues. J. Pharm. Exp. Ther. 211: 502-508.
22. Weiland, G.A., Minneman, K.P. and Molinoff, P.B. (1979) Fundamental difference between the molecular interactions
of agonists and antagonists with the β-adrenergic receptor. Nature 281: 114-117.
23. Molinoff, P.B., Wolfe, B.B., Minneman, K.P. and Dibner, M.D. (1979) Regulation of β-adrenergic receptors in rat
cerebral cortex. In "Catecholamines: Frontiers in Basic and Clinical Research" ed. E. Usdin, I.J. Kopin and J.
Barchas, Pergamon Press, 580-582.
24. Minneman, K.P. and Molinoff, P.B. (1979) Catecholamine receptors in the central nervous system: multiple subtypes.
In "Catecholamines: Frontiers in Basic and Clinical Research" ed. E. Usdin, I.J. Kopin and J. Barchas, Pergamon
Press, 468-473.
25. Hedberg, A., Minneman, K.P. and Molinoff, P.B. (1980) Differential distribution of β1- and β2-adrenergic receptors in
cat and guinea pig heart. J. Pharm. Exp. Ther. 212: 503-508.
Articles (continued)

26. Pittman, R.N., Minneman, K.P. and Molinoff, P.B. (1980) Alterations in β1- and β2-adrenergic receptor density in the
cerebellum of aging rats. J. Neurochem. 35: 273-275.
27. Minneman, K.P., Weiland, G.A. and Molinoff, P.B. (1980) A comparison of the β-adrenergic receptor of the turkey
erythrocyte with mammalian β1- and β2-receptors. Mol. Pharmacol. 17: 1-7.
28. Pittman, R.N., Minneman, K.P. and Molinoff, P.B. (1980) Ontogeny of β1- and β2-adrenergic receptors in rat cerebral
cortex and cerebellum. Brain Research 188: 357-368.
29. Weiland, G.A., Minneman, K.P. and Molinoff, P.B. (1980) Thermodynamics of agonist and antagonist interactions
with mammalian β-adrenergic receptors. Mol. Pharmacol. 18: 341-347.
30. Minneman, K.P. and Molinoff, P.B. (1980) Classification and quantitation of β-adrenergic receptor subtypes.
Biochem. Pharmacol. 29: 1317-1323.
31. Molinoff, P.B. and Minneman, K.P. (1980) Biochemical and functional aspects of the interactions of agonists and
antagonists with β-adrenergic receptors. (In) "Psychopharmacology and Biochemistry of Neurotransmitter Receptors".
Ed. H. Yamamura, R. Olsen and E. Usdin, Elsevier North Holland, Inc., pp. 171-182.
32. Minneman, K.P., Pittman, R.N., Yeh, H., Woodward, D.J., Wolfe, B.B. and Molinoff, P.B. (1981) Selective survival
of β1-adrenergic receptors in rat cerebellum after neonatal X-irradiation. Brain Res. 209: 25-34.
33. Minneman, K.P., Pittman, R.N. and Molinoff, P.B. (1981) β-Adrenergic receptor subtypes: properties, distribution
and regulation. Annual Review of Neuroscience 4: 419-461.
34. Molinoff, P.B., Weiland, G.A., Heidenreich, K.A., Pittman, R.N. and Minneman, K.P. (1981) Interactions of agonists
and antagonists with β-adrenergic receptors. Advances in Cyclic Nucleotide Res. 14: 51-67.
35. Minneman, K.P. (1981) Adrenergic Receptor Molecules. In "Neurotransmitter Receptors", Part II, ed. H. Yamamura
and S. Enna. Chapman and Hall, London. pp. 185-268.
36. Wolfe, B.B., Minneman, K.P. and Molinoff, P.B. (1982) Selective increases in the density of cerebellar β1-adrenergic
receptors. Brain Research 234: 474-479.
37. Minneman, K.P., Wolfe, B.B. and Molinoff, P.B. (1982) Selective changes in the density of β1-adrenergic receptors in
rat striatum following chronic drug treatment and adrenalectomy. Brain Research 252: 309-314.
38. Minneman, K.P. (1983) Peripheral catecholamine administration does not alter cerebral β-adrenergic receptor density.
Brain Research 264: 328-331.
39. Minneman, K.P., Fox, A.W. and Abel, P.W. (1983) Occupancy of α1-adrenergic receptors and contraction of rat vas
deferens. Mol. Pharmacol. 23: 359-368.
40. Minneman, K.P., Puckett, M., Jensen, A.D. and Rinard, G.A. (1983) Regional variation in β-adrenergic receptors in
dog trachea: Correlation of receptor density and in vitro relaxation. J. Pharm. Exp. Ther. 226: 140-146.
41. Minneman, K.P. (1983) Binding properties of α1-adrenergic receptors in rat cerebral cortex: Similarity to smooth
muscle. J. Pharm. Exp. Ther. 227: 605-612.
42. Minneman, K.P. (1983) Phenoxybenzamine is more potent in inactivating α1- than α2-adrenergic receptor binding
sites. Eur. J. Pharmacol. 94: 171-174.
43. Minneman, K.P., Wolfe, B.B., Pittman, R.N. and Molinoff, P.B. (1983) β-Adrenergic receptor subtypes in rat brain.
In Adv. Biochem. Psychopharmacol. 36: 73-82.
44. Minneman, K.P. and Abel, P.W. (1984) "Spare" α1-adrenergic receptors and the potency of agonists in rat vas
deferens. Mol. Pharmacol. 25: 56-63.
45. Minneman, K.P. and Holtzman, S.G. (1984) Morphine dependence and withdrawal can occur without alterations in
cerebral β-adrenergic receptor density. Biochem. Pharmacol 33: 2331-2333.
46. Minneman, K.P. and Johnson, R.D. (1984) Characterization of α1-adrenergic receptors liked to 3
H-inositol metabolism
in rat cerebral cortex. J. Pharm. Exp. Ther. 230: 317-323.
47. Minneman, K.P. and Abel, P.W. (1984) Relationship between α1-adrenergic receptor density and functional response
of rat vas deferens: Studies with phenoxybenzamine. Naunyn Schmiedeberg's Arch. Pharmacol. 327: 238-246.
48. Minneman, K.P. (1984) Dynamics of cell-surface receptors. Eur. J. Respiratory Diseases 65 (Suppl. 135): 7-15.
49. Minneman, K.P. (1984) Receptor Thermodynamics. In "Monographs Neural Sci." Vol. 10 J. Marwaha and W.
Anderson, Ed., S. Karger, Basel, p. 20-26.
50. Sutin, J. and Minneman, K.P. (1985) α1- and β-adrenergic receptors are co-regulated during both noradrenergic
denervation and hyperinnervation. Neuroscience 14: 973-980.

51. Johnson, R.D. and Minneman, K.P. (1985) α1-Adrenergic receptors and stimulation of 3
H-inositol metabolism in rat
brain: Regional distribution and parallel inactivation. Brain Research 341: 7-15.
52. Abel, P.W., Johnson, R.D., Martin, T.J. and Minneman, K.P. (1985) Sympathetic denervation does not alter the
density or properties of α1-adrenergic receptors in rat vas deferens. J. Pharmacol. Exp. Ther. 233: 570-577.
53. Sutin, J. and Minneman, K.P. (1985) Adrenergic beta receptors are not uniformly distributed in the cerebellar cortex.
J. Comp. Neurol. 236: 547-554.
54. Abel, P.W., Fox, A.W. and Minneman, K.P. (1985) Effects of isoxsuprine and nylidrin on adrenergic receptors in rat
vas deferens. J. Autonom. Pharmacol. 5: 213-219.
55. Nasseri, A., Barakeh, J.F., Abel, P.W. and Minneman, K.P. (1985) Reserpine-induced postjunctional supersensitivity
in rat vas deferens and caudal artery without changes in α-adrenergic receptors. J. Pharmacol. Exp. Ther. 234: 350-
357.
56. Fox, A.W., Abel, P.W. and Minneman, K.P. (1985) Activation of α1-adrenergic receptors increases 3
H-inositol
metabolism in rat vas deferens and caudal artery. Eur. J. Pharmacol. 116: 145-152.
57. Juberg, E.J., Minneman, K.P. and Abel, P.W. (1985) β1- and β2-adrenoceptor binding and functional response in right
and left atria of rat heart. Naunyn-Schmiedeberg's Arch. Pharmacol. 330: 193-202.
58. Fox, A.W., Juberg, E.N., May, J.M., Johnson, R.D., Abel, P.W. and Minneman, K.P. (1985) Thyroid status and
adrenergic receptor subtypes in the rat: Comparison of receptor density and responsiveness. J. Pharmacol. Exp. Ther.
235: 715-723.
59. May, J.M., Abel, P.W. and Minneman, K.P. (1985) Binding of agonists and antagonists to β-adrenoceptors in rat vas
deferens: Relationship to functional response. Naunyn-Schmiedeberg's Arch. Pharmacol. 331: 324-333.
60. Minneman, K.P. and Mowry, C.B. (1986) Interactions of putatively irreversible antagonists with β1- and β2-adrenergic
receptors. Biochemical Pharmacol. 35: 857-864.
61. May, J.M., Abel, P.W. and Minneman, K.P. (1986) Regulation of β-adrenoceptor density and function in rat vas
deferens. Eur. J. Pharmacol. 122: 221-229.
62. Bazil, C.W. and Minneman, K.P. (1986) An investigation of the low intrinsic activity of adenosine and its analogs at
low affinity (A2) adenosine receptors in rat cerebral cortex. J. Neurochem. 47: 547-553.
63. Johnson, R.D. and Minneman, K.P. (1986) Characterization of α1-adrenoceptors which increase cyclic AMP
accumulation in rat cerebral cortex. Eur. J. Pharmacol. 129: 293-305.
64. Abel, P.W. and Minneman, K.P. (1986) α1-Adrenergic receptor binding and contraction of rat caudal artery. J.
Pharmacol. Exp. Ther. 239: 678-686.65.May, J.M. and Minneman, K.P. (1986) Adrenergic Receptor Molecules in
"Neuromethods" Vol. 4, Ed., A.A. Boulton, G.B. Baker and P.D. Hrdina. Humana Press, Clifton, New Jersey, 55-92.
66. Johnson, R.D. and Minneman, K.P. (1987) Differentiation of α1-adrenergic receptors linked to phosphatidylinositol
turnover and cyclic AMP accumulation in rat brain. Mol. Pharmacol. 31: 239-246.
67. Johnson, R.D., Iuvone, P.M. and Minneman, K.P. (1987) Regulation of α1-adrenergic receptor density and functional
responsiveness in rat brain. J. Pharmacol. Exp. Ther. 242: 842-849.
68. Bazil, C.W., Raux, M.E., Yudell, S. and Minneman, K.P. (1987) Equilibration of halothane with brain tissue in vitro:
Comparison to brain concentrations during anesthesia. J. Neurochem. 49: 952-958.
69. Han, C., Abel, P.W. and Minneman, K.P. (1987) Heterogeneity of α1-adrenergic receptors revealed by
clorethylclonidine. Mol. Pharmacol. 32: 505-510.
70. Nasseri, A. and Minneman, K.P. (1987) Relationship between α2-adrenergic receptor binding sites and the functional
receptors inhibiting norepinephrine release in rat cerebral cortex. Mol. Pharmacol. 32: 655-662.
71. Han, C., Abel, P.W. and Minneman, K.P. (1987) α1-Adrenoceptor subtypes linked to different mechanisms for
increasing intracellular Ca2+ in smooth muscle. Nature 329: 333-335.
72. Minneman, K.P. and Abel, P.W. (1987) Relationship of alpha-1 adrenergic receptor occupancy to tissue response, in
"The Alpha-1 Adrenergic Receptors" Ed. R.R. Ruffolo, Jr., Humana Press, Clifton, New Jersey, 267-324.
73. Minneman, K.P. and Johnson, R.D. (1987) α1-Adrenergic receptors linked to inositol phosphate and cyclic AMP
accumulation in rat brain. In "Synaptic Transmitters and Receptors" John Wiley and Sons, Chichester, 310-314.
74. Minneman, K.P., Mumford, G.K. and Abel, P.W. (1988) High efficiency coupling of α1-adrenergic receptors to
inositol phospholipid metabolism revealed by denervation of rat vas deferens. J. Pharm. Exp. Ther. 244: 226-230.
75. Minneman, K.P., Han, C. and Abel, P.W. (1988) Comparison of α1-adrenergic receptor subtypes distinguished by
chlorethylclonidine and WB 4101. Mol. Pharmacol. 33:509-514.

76. May, J.M., Abel, P.W. and Minneman, K.P. (1988) Spare β-adrenergic receptors: Relationship to agonist binding. In
"Progress in Catecholamine Research Part A: Basic Aspects and Peripheral Mechanisms", Alan R. Liss, Inc., p. 363-
367.
77. Minneman, K.P. (1988) α1-Adrenergic receptor subtypes, inositol phosphates, and sources of cell Ca2+
. Pharmacol.
Rev. 40: 87-119.
78. Minneman, K.P. (1988) β-Adrenergic receptor subtypes. ISI Atlas of Science: Pharmacology 2: 334-338.
79. Bazil, C.W. and Minneman, K.P. (1989) Effects of clinically effective concentrations of halothane on adrenergic and
cholinergic synapses in rat brain in vitro. J. Pharmacol. Exp. Ther. 248: 143-148.
80. Wilson, K.M. and Minneman, K.P. (1989) Regional variations in α1-adrenergic receptor subtypes in rat brain. J.
Neurochem. 53: 1782-1786.
81. Bazil, C.W. and Minneman, K.P. (1989) Clinical concentrations of volatile anesthetics reduce depolarization-evoked
release of 3
H-norepinephrine, but not 3
H-acetylcholine, from rat cerebral cortex. J Neurochem. 53: 962-965.
82. Bazil, C.W. and Minneman, K.P. (1989) Anesthetic concentrations of enflurane and methoxyflurane in rat brain in vivo
and in vitro. J. Pharm. Pharmacol. 41: 835-839.
83. Minneman, K.P. (1991) Pharmacological organization of the central nervous system, in "Human Pharmacology:
Molecular-to-Clinical" ed. L.B. Wingard, Jr., T.M. Brody, J. Larner, and A. Schwartz. C.V. Mosby Co., St. Louis,
MO, 299-331.
84. Mante, S. and Minneman, K.P. (1990) Caffeine inhibits forskolin-stimulated cyclic AMP accumulation in rat brain.
Eur. J. Pharmacol. 175: 203-205.
85. Han, C., Wilson, K.M. and Minneman, K.P. (1990) α1-Adrenergic receptor subtypes and formation of inositol
phosphates in dispersed hepatocytes and renal cells. Mol. Pharmacol. 37: 903-910.
86. Wilson, K.M., Gilchrist, S. and Minneman, K.P. (1990) Comparison of α1-adrenergic receptor stimulated inositol
phosphate formation in primary neuronal and glial cultures. J. Neurochem. 55: 691-697.
87. Wilson, K.M. and Minneman, K.P. (1990) Pertussis toxin inhibits norepinephrine-stimulated inositol phosphate
formation in primary brain cell cultures. Mol. Pharmacol. 38: 274-286.
88. Wilson, K.M. and Minneman, K.P. (1990) Different pathways of 3
H-inositol phosphate formation mediated by α1a- and
α1b-adrenergic receptors. J. Biol. Chem. 265: 17601-17606.
89. Minneman, K.P., Wilson, K.M. and Han, C. (1990) α1-Adrenergic receptor subtypes: Pharmacology and signal
transduction. in "Adrenoceptors: Structure, mechanisms, function" ed. E. Szabadi and C.M. Bradshaw, Birkhauser
Verlag, Basel, 15-25.
90. Han, C., Li, J. and Minneman, K.P. (1990) Subtypes of α1-adrenoceptors in rat blood vessels. Eur. J. Pharmacol. 190:
97-104.
91. Mante, S. and Minneman, K.P. (1990) Is adenosine involved in inhibition of forskolin-stimulated cyclic AMP
accumulation by caffeine in rat brain? Mol. Pharmacol. 38: 652-659.
92. Atkinson, B.A. and Minneman, K.P. (1991) Multiple adrenergic receptor subtypes controlling cyclic AMP formation:
Comparison of brain slices and primary neuronal and glial cultures. J. Neurochem. 56:587-595.
93. Holtzman, S.G., Mante, S. and Minneman, K.P. (1991) Role of adenosine receptors in caffeine tolerance. J.
Pharmacol. Exp. Ther. 256:62-68.
94. Wilson, K.M. and Minneman, K.P. (1991) Synergistic interactions between α1- and α2-adrenergic receptors in
activating inositol phosphate accumulation in primary glial cell cultures. J. Neurochem. 56: 953-960.
95. Wigginton, S.A. and Minneman, K.P. (1991) Comparison of calcium ionophore and receptor-activated inositol
phosphate formation in primary glial cell cultures. Eur. J. Pharmacol. Mol. Pharm. 208: 239-247.
96. Mante, S. and Minneman, K.P. (1991) The alkylating prazosin analog SZL 49 inactivates both α1A- and α1B- adrenergic
receptors. Eur. J. Pharmacol. Mol. Pharm. 208: 113-117.
97. Minneman, K.P. and Atkinson, B.A. (1991) Interaction of subtype selective antagonists with α1- adrenergic receptor
mediated second messenger responses in rat brain. Mol. Pharmacol. 40: 523-530.
98. Han C. and Minneman, K.P. (1991) Interaction of subtype selective antagonists with α1- adrenergic receptor binding
sites in rat tissues. Mol. Pharmacol. 40: 531-538.
99. Minneman, K.P., Esbenshade, T.A. and Han, C. (1992) Subtypes of α-adrenoceptors in contraction of vascular smooth
muscle. Japanese J. Pharmacol. 58, Supp. II: 128P-134P.

Articles (continued):
100. Atkinson, B.A. and Minneman, K.P. (1992) Preferential desensitization of β- over α2-adrenergic receptors accelerates
loss of response to norepinephrine in primary glial cultures. Mol. Pharmacol. 41: 688-694.
101. Esbenshade, T.A., Han, C., Theroux, T.L., Granneman, J.G. and Minneman, K.P. (1992) Co-existing β1- and atypical
β-adrenergic receptors cause redundant increases in cyclic AMP in human neuroblastoma cells. Mol. Pharmacol. 42:
753-759.
102. Han, C., Esbenshade, T.A. and Minneman, K.P. (1992) Subtypes of α1-adrenoceptors in DDT1-MF-2 and BC3H-1
clonal cell lines. Eur. J. Pharmacol. Mol. Pharmacol. 226: 141-148.
103. Esbenshade, T.A. and Minneman, K.P. (1992) Adrenergic receptor subtypes: Pharmacological approaches.
Neuroprotocols 4: 2-13.
104. Atkinson, B.A. and Minneman, K.P. (1992) Occupancy-response relationships for β- and α2-adrenergic receptors
exerting opposing effects on cyclic AMP production. Receptor 2: 195-206.
105. Esbenshade, T.A., Han, C. and Minneman, K.P. (1993) [3
H] - Prazosin does not distinguish α1-adrenoceptor subtypes
in rat tissues. Pharmacology Communications 3: 323-332.
106. Esbenshade, T.A., Han, C., Murphy, T.J. and Minneman, K.P. (1993) Comparison of α1-adrenergic receptor subtypes
and signal transduction in SK-N-MC and NB41A3 neuronal cell lines. Mol. Pharmacol. 44: 76-86.
107. Minneman, K.P., Esbenshade, T.A. and Zhong, H. (1993) Interactions between co-existing β-adrenoceptor subtypes in
continuous cell lines. Biochem. Soc. Trans. 21: 1109-1114.
108. Zhong, H. and Minneman, K.P. (1993) Close reciprocal regulation of β1- and β2- adrenergic receptors by
dexamethasone in C6 glioma cells: Effects on catecholamine responsiveness. Mol. Pharmacol. 44:1085-1093.
109. Minneman, K.P. and Esbenshade, T.A. (1994) α1-Adrenergic receptor subtypes. Ann. Rev. Pharmacol. Toxicol. 34:
117-133.
110. Miranda, H.F., Ramirez, H., Castillo, O., Minneman, K.P. and Pinardi, G. (1994) α1A-Adrenergic receptors in the
isolated human prostate. Pharmacol. Comm. 4: 181-188.
111. Esbenshade, T.A., Theroux, T.L. and Minneman, K.P. (1994) Increased voltage-dependent calcium influx by α1B-
adrenergic receptor activation in rat rMTC 6-23 cells. Mol. Pharmacol. 45: 591-598.
112. Minneman, K.P., Theroux, T.L., Hollinger, S., Han, C. and Esbenshade, T.A. (1994) Selectivity of agonists for cloned
α1-adrenergic receptor subtypes. Mol. Pharmacol. 46: 929-936.
113. Bylund, D.B., Eikenberg, D.C., Hieble, J.P., Langer, S.Z., Lefkowitz, R.J., Minneman, K.P., Molinoff, P.B., Ruffolo,
R.R., Jr., and Trendelenburg, U. (1994). International union of pharmacology nomenclature of adrenoceptors.
Pharmacol. Rev. 46: 121-136.
114. Minneman, K.P. (1994) Pharmacological organization of the CNS in "Human Pharmacology: Molecular to Clinical"
2nd edition, ed. T.M. Brody, J. Larner, K.P. Minneman and H. Neu. C.V. Mosby Co., St. Louis, MO. 293-320.
115. Minneman, K.P. and Brody, T.M. (1994) Local anesthetics in "Human Pharmacology: Molecular to Clinical" 2nd
edition, ed. T.M. Brody, J. Larner, K.P. Minneman and H. Neu. C.V. Mosby Co., St. Louis, MO 402-408.
116. Han, C., Hollinger, S., Theroux, T.L., Esbenshade, T.A. and Minneman, K.P. (1995) 3
H-Tamsulosin binding to cloned
α1-adrenergic receptor subtypes expressed in human embryonic kidney 293 cells: Antagonist potencies and sensitivity
to alkylating agents. Pharmacol. Comm. 5: 117-126.
117. Garcia-Sainz, J.A., Romero-Avila, M.T., Villalobos-Molina, R. and Minneman, K.P. (1995) α1-Adrenergic subtype
selectivity of tamsulosin. Studies using livers from different species. Eur. J. Pharmacol. Mol. Pharm. 289: 1-8.
118. Zhong, H. and Minneman, K.P. (1995) Coexisting β1- and β2-adrenergic receptors have differential receptor reserves
in rat C6 glioma cells. J. Pharmacol. Exp. Ther. 272: 1088-1094.
119. Esbenshade, T.A., Wang, X., Williams, N.G. and Minneman, K.P. (1995) Inducible expression of α1B-adrenoceptors
in DDT1-MF-2 cells: Comparison of density and response. Eur. J. Pharmacol. Mol. Pharmacol. 289: 305-310.
120. Esbenshade, T.A. and Minneman, K.P. (1995) Signal transduction by α1-adrenergic receptor subtypes in continuous
cell lines. Pharmacol. Comm. 6: 39-45.
121. Esbenshade, T.A., Hirasawa, A., Tsujimoto, G., Tanaka, T., Yano, J., Minneman, K.P. and Murphy, T.J. (1995)
Cloning of the human α1A/D-adrenergic receptor and inducible expression of three human subtypes in SKNMC cells.
Mol. Pharmacol. 47: 977-985.
122. Hieble, J.P., Bylund, D.B., Clarke, D.E., Eikenburg, D.C., Langer, S.Z., Lefkowitz, R.J., Minneman, K.P., Ruffolo,
R.R., Jr. (1995) International Union of Pharmacology. X. Recommendation for nomenclature of α1-adrenoceptors:
consensus update. Pharmacol Rev. 47:267-270.

123. Theroux, T.L., Esbenshade, T.A. and Minneman, K.P. (1996) α1-Adrenergic receptor subtypes and signal
transduction. Perspectives in Receptor Research, Giardina, P., Piergentili, A., and Pigini, M. (Ed.) Elsevier,
Amsterdam. 121-133.
124. Guerrero, S.W., Zhong, H. and Minneman, K.P. (1996) Selective desensitization of β1- and β2-adrenergic receptors
in C6 glioma cells: Effects on catecholamine responsiveness. Receptor 5: 185-195.
125. Zhong, H., Guerrero, S.W., Esbenshade, T.A. and Minneman, K.P. (1996) Inducible expression of β1- and β2-
adrenergic receptors in C6 glioma cells: Functional interactions between closely related subtypes. Mol. Pharmacol.
50: 175-184.
126. Theroux, T.L., Esbenshade, T.A., Peavy, R.D. and Minneman, K.P. (1996) Coupling efficiencies of human α1-
adrenergic receptor subtypes: Titration of receptor density and responsiveness with inducible and repressible
expression vectors. Mol. Pharmacol. 50: 1376-1387.
127. McCullough, J.R., Aberg, G., Smith, E.R., and Minneman, K.P. (1997) The binding of doxazosin and its
enantiomers to α1-adrenoceptor subtypes. Pharmacol. Rev. and Comm. 9: 191-196.
128. Williams, N.G., Zhong, H. and Minneman, K.P. (1998) Differential coupling of α1-, α2-, and β-adrenergic receptors
to MAP kinase pathways and differentiation in transfected PC12 cells. J. Biol. Chem. 273: 24624-24632.
129. Minneman, K.P. Pharmacological Organization of the CNS. (1998) In “Human Pharmacology: Molecular to
Clinical.” C.V. Mosby Co., St. Louis, MO, Third edition. Ed. Brody, Larner, and Minneman, pp. 313-337.
130. Berts, A., Zhong, H., and Minneman, K.P. (1999) No role for Ca2+
or protein kinase C in MAP kinase activation by
α1A-adrenergic receptors expressed in PC12 cells. Mol. Pharmacol. 55: 296-303.
131. Zhong, H., and Minneman, K.P. (1999) Differential activation of mitogen-activated protein kinase pathways in PC12
cells by closely-related α1-adrenergic receptor subtypes. J. Neurochem. 72: 2388-2396.
132. Zhong, H. and Minneman, K.P. (1999) α1-Adrenoceptor subtypes. Eur. J. Pharmacol. 375: 261-276.
133. Guerrero, S.W. and Minneman, K.P. (1999) Relative coupling efficiencies of β1- and β2-adrenergic receptors
expressed alone or together in GH3 pituitary cells. J. Pharmacol. Exp. Ther. 290:980-988.
134. Zhong, H. and Minneman, K.P. (1999) Activation of tyrosine kinases by α1A-adrenergic and growth factor receptors
in transfected PC12 cells. Biochem. J. 344: 889-894.
135. Zhong, H. and Minneman, K.P. (2000) Use and pharmacological analysis of established and transfected cell lines
expressing adrenergic receptors. Methods Mol. Biol. 126: 221-234.
136. Berts, A. and Minneman, K.P. (2000) Tyrosine Kinase Inhibitors and Calcium Signaling: Direct Interactions with
Fura-2. Eur. J. Pharmacol. 389: 35-40.
137. Zhong, H., Murphy, T.J., and Minneman, K.P. (2000) Activation of Stats by α1A-adrenergic receptor stimulation in
PC12 cells. Mol. Pharmacol. 57: 961-967.
138. Minneman, K.P., Lee, D., Zhong, H.Y., Berts, A., Abbott, K.L. and Murphy, T.J. (2000) Transcriptional responses
to growth factor and G protein coupled receptors in PC12 cells: Comparison of α1-adrenergic receptor subtypes. J.
Neurochem. 74: 2392-2400.
139. Zhong, H., Lee, D., Robeva, A. and Minneman, K.P. (2001) Signaling pathways activated by α1-adrenergic receptor
subtypes in PC12 cells. Life Sci. 68: 2269-2276.
140. Minneman, K.P. (2001) Splice variants of G protein coupled receptors. Molecular Interventions 1: 108-116.
141. Pupo, A.S. and Minneman, K.P. (2001) Adrenergic pharmacology: Focus on the CNS. CNS Spectrums 6: 656-662.
142. Vicentic, A., Robeva, A., Rogge, G., Uberti, M. and Minneman, K.P. (2002) Biochemistry and pharmacology of
epitope tagged α1-adrenergic receptor subtypes expressed in HEK 293 cells. J. Pharmacol. Exp. Ther. 302: 58-65.
143. Pupo, A. and Minneman, K.P. (2002) Interactions of neuronal nitric oxide synthase with α1-adrenergic receptor
subtypes in transfected HEK-293 cells. BMC Pharmacology 2: 17-23.
144. Pupo, A., Uberti, M.A. and Minneman, K.P. (2003) N-Terminal truncation of human α1D-adrenoceptors increases
expression of binding sites but not protein. Eur. J. Pharmacol. 462: 1-8.
145. Romeo, G., Materia, L., Manetti, F., Cagnotto, A., Mennini, T., Niicoletti, F., Botta, M., Russo, F. and Minneman,
K.P. (2003) New Pyrimido[5,4-b]indoles as Ligands for α1-Adrenoceptor Subtypes. J. Med. Chem. 46: 2877-2894.
146. Lee, D., Robeva, A., Chen, Z. and Minneman, K.P. (2003) Mutational uncoupling of α1A-adrenergic receptors from G
proteins also uncouples mitogenic and transcriptional responses in PC12 cells. J. Pharmacol. Exp. Ther. 306: 471-
477.

147. Uberti, M.A., Hall, R.A. and Minneman, K.P. (2003) Subtype-specific dimerization of α1-adrenoceptors: Effects on
receptor expression and pharmacological properties. Mol. Pharmacol. 64: 1379-1390.
148. Pupo, A.S. and Minneman, K.P. (2003) Specific interactions between gC1qR and α1-adrenoceptor subtypes. J.
Receptors Signal Transduction 23: 185-195.
149. Hague, C., Chen, Z., Uberti, M. and Minneman, K.P. (2003) α1-Adrenergic receptor subtypes: Non-identical triplets
with different dancing partners? Life Sci. 12: 411-418.
150. Hague, C., Chen, Z., Pupo, A.S., Schulte, N.A., Toews, M.L. and Minneman, K.P. (2004) The N-terminus of the
human α1D-adrenergic receptor prevents cell surface expression. J. Pharmacol. Exp. Ther. 309: 388-397.
151. Hague, C., Uberti, M.A., Chen, Z., Hall, R.A. and Minneman, K.P. (2004) Cell surface expression of α1D-ARs is
controlled by heterodimerization with α1B-adrenergic receptors. J. Biol. Chem. 279: 15541-15549.
152. Romeo, G., Materia, L., Salerno, L., Russo, F. and Minneman, K.P. (2004) Novel antagonists for the α1-adrenoceptor
subtypes. Expert Opinion on Therapeutic Patents 14: 619-637.
153. Chen, Z., Rogge, G., Hague, C., Alewood, D., Colless, B., Lewis, R.J. and Minneman, K.P. (2004) Subtype-selective
noncompetitive or competitive inhibition of human α1-adrenergic receptors by ρ-TIA. J. Biol. Chem. 279: 35326-
35333.
154. Hague, C., Uberti, M.A., Chen, Z., Bush, C.F., Jones, S.V., Ressler, K.J., Hall, R.A., and Minneman, K.P. (2004)
Olfactory receptor surface expression is driven by association with the β2-adrenergic receptor. Proc. Nat. Acad. Sci.
USA 101: 13672-13676.
155. Hague, C., Hall, R.A. and Minneman, K.P. (2004) Olfactory Receptor Localization and Function: An Emerging Role
for GPCR Heterodimerization. Molecular Inverventions 4: 321-322.
156. Lima, V., Raymundi, V., Kamakihara, S.Y., Mueller, A., Alewood, D., Lewis, R.J., Chen, Z., Minneman, K.P., and
Pupo, A.S. (2005) Differential antagonism by conotoxin ρ-TIA of contractions mediated by distinct α1-adrenergic
receptor subtypes in rat vas deferens, spleen and aorta. Eur. J. Pharmacol. 508: 183-192.
157. Uberti, M.A., Hague, C., Oller, H., Minneman, K.P. and Hall, R.A. (2005) Heterodimerization with β2-adrenergic
receptors promotes surface expression and functional activity of α1D-adrenergic receptors. J. Pharm. Exp. Ther. 313:
16-23.
158. Minneman, K.P. and Garrison, J.C. (2005) Receptors and concentration-response relationships. in “Brody’s Human
Pharmacology: Molecular to Clinical”, Minneman, K.P. and Wecker, L. ed., Elsevier/Mosby, Philadelphia, PA; 4th
edition 9-26.
159. Minneman, K.P. (2005) Drugs affecting the sympathetic nervous system. in “Brody’s Human Pharmacology:
Molecular to Clinical”, Minneman, K.P. and Wecker, L. ed., Elsevier/Mosby, Philadelphia, PA; 4th
edition 119-138.
160. Wecker, L. and Minneman, K.P. (2005) Skeletal muscle relaxants. in “Brody’s Human Pharmacology: Molecular to
Clinical”, Minneman, K.P. and Wecker, L. ed., Elsevier/Mosby, Philadelphia, PA; 4th
edition 355-364.
161. Hague, C., Bernstein, L.S., Ramineni, S., Chen, Z.J., Minneman, K.P. and Hepler, J.R. (2005) Selective inhibition of
α1A-adrenergic receptor signaling by RGS2 association with the receptor third intracellular loop. J. Biol. Chem. 280:
27289-27295.
162. Chen, Z.J. and Minneman, K.P. (2005) Recent progress in α1-adrenergic receptor research. Acta Pharmacologica
Sinica 26: 1281-1287.
163. Minneman, K.P. (2006) New signal transduction paradigms. In “Adrenergic Receptors in the 21st Century” 87-106.
ed. D. Perez. Humana Press.
164. Romeo, G., Materia, L., Pittalà, V., Modica, M., Salerno, L., Siracusa, M., Russo, F., and Minneman, K.P. (2006)
New 1,2,3,9-Tetrahydro-4H-carbazol-4-one Derivatives. Analogues of HEAT as Ligands for the α1-Adrenergic
Receptor Subtypes. Bioorganic and Medicinal Chemistry 14: 5211-5219.
165. Hague, C., Lee, S., Prinster, S.C., Chen, Z.J., Hall, R.A., and Minneman, K.P. (2006) Heterodimers of α1B and α1D-
adrenergic receptors form a single functional entity. Mol. Pharmacol. 69:45-55.
166. Kuhar, M.J., Minneman, K.P. and Muly, C. (2006) Catecholamines. In Basic Neurochemistry. 7th Edition. ed. G.
Siegel et al. Elsevier 211-225.
167. Chen, Z.J., Hague, C., Hall, R.A. and Minneman, K.P. (2006) Syntrophins regulate α1D-adrenergic receptors through
a PDZ-domain-mediated interaction. J. Biol. Chem. 281: 12414-12420.
168. Romeo, G., Materia, L., Marucci, G., Modica, M., Pittalia, V., Salerno, L., Siracusa, M.A., Angeli, P. and
Minneman, K.P. (2006) New Pyrimido[5,4-b]indoles and [1]Benzothieno[3,2-d] pyrimidines. High Affinity Ligands
for the α1-Adrenoceptor Subtypes. Bioorganic and Medicinal Chemistry Letters 16: 6200-6203.

169. Minneman, K.P. (2007) Heterodimerization and Surface Localization of G Protein Coupled Receptors. Biochemical
Pharmacology 73: 1043-1050.
170.Bush, C.F., Jones, S.V., Lyle, A.N., Minneman, K.P., Ressler, K.J. and Hall, R.A. (2007) Specificity of olfactory
receptor interactions with other G protein coupled receptors. J. Biol. Chem 282: 19042-19051.
171. Sagar, S., Kaur, M., Minneman, K.P., Bajic, V.B. (2010) Anti-cancer activities of diospyrin, its derivatives and
analogues. Eur. J. Med. Chem. 45:3519-30.
172. Sagar, S., Kaur, M., Minneman, K.P. (2010) Antiviral lead compounds from marine sponges. Marine Drugs 8:2619-
38.
173. Romeo, G., Materia, L., Modica, M.N., Pittalà, V., Salerno, L., Siracusa M.A., Manetti F., Botta M., Minneman K.P.
(2011) Novel 4-phenylpiperidine-2,6-dione derivatives. Ligands for α1-adrenoceptor subtypes. Eur. J. Med. Chem.
46:2676-90.
174. Sagar,S., Gehring,C., Minneman, K.P. (2012) Methods to isolate and identify new plant signaling peptides. Plant
Signaling Peptides ed. Helen Irving and Chris Gehring, Springer. 217-239.
175. Romeo, G., Salerno, L., Pittalà, V., Modica, M.N., Siracusa, M.A,, Materia, L., Buccioni, M., Marucci, G.,
Minneman, K.P. (2014) High affinity ligands and potent antagonists for the α1D-adrenergic receptor. Novel 3,8-
disubstituted (1)benzothieno(3,2d)pyrimidine derivatives Eur. J. Med Chem. 83: 419-32.
Textbooks:
1. Brody, T.M., Larner, J., Minneman, K.P. and Neu, H. (1994) Human Pharmacology: Molecular to Clinical. C.V.
Mosby Co., St. Louis, MO, Second edition.
2. Brody, T.M., Larner, J., and Minneman, K.P. (1998) Human Pharmacology: Molecular to Clinical. C.V. Mosby Co.,
St. Louis, MO, Third edition.
3. Minneman, K.P. and Wecker, L (2005) Brody’s Human Pharmacology: Molecular to Clinical. Elsevier/Mosby,
Philadelphia, PA, Fourth edition.

Abstracts:
1. Minneman, K.P. (1977) Morphine selectively blocks dopamine stimulated cyclic AMP accumulation in slices of rat
neostriatum. Brit. J. Pharmacol. 59: 480-481P.
2. Hedberg, A., Minneman, K.P. and Molinoff, P.B. (1979) Regional distribution of β1- and β2-adrenoceptors in the right
atrium and left ventricle of cat and guinea heart. Brit. J. Pharmacol. 66: 505P.
3. Minneman, K.P., Wolfe, B.B., Dibner, M.D. and Molinoff, P.B. (1979) β1- and β2-Adrenergic receptors in rat cerebral
cortex have different endogenous inputs. Fed. Proc. 38: 1922.
4. Minneman, K.P., Pittman, R.N., Molinoff, P.B. and Woodward, D.J. (1979) Cellular localization of β1- and β2-
adrenergic receptors in rat cerebellum. Neuroscience Abstracts 5: 105.
5. Weiland, G.A., Minneman, K.P. and Molinoff, P.B. (1979) Thermodynamic evidence for an agonist-specific
conformational change of the β-adrenergic receptor. Neuroscience Abstracts 5: 576.
6. Pittman, R.N., Minneman, K.P. and Molinoff, P.B. (1979) Ontogeny of β1- and β2-adrenergic receptors in rat
cerebellum and cerebral cortex. Neuroscience Abstracts 5: 174.
7. Wolfe, B.B., Minneman, K.P., Dibner, M.D. and Molinoff, P.B. (1980) Regulation of β-adrenergic receptor subtypes
in rat cerebellum, cerebral cortex and caudate. Neuroscience Abstracts 6.
8. Molinoff, P.B., Wolfe, B.B., Pittman, R.N. and Minneman, K.P. (1980) β-Adrenergic receptor subtypes in rat cerebral
cortex and cerebellum. At "International Symposium on Adrenergic Receptor Pharmacology" Southeast
Pharmacological Society. Augusta, Georgia.
9. Minneman, K.P., Wolfe, B.B., Pittman, R.N. and Molinoff, P.B. (1981) β-Adrenergic receptor subtypes in rat brain.
"Symposium on Molecular Pharmacology of Neurotransmitter Receptor Systems", Hiroshima, Japan.
10. Minneman, K.P., Wolfe, B.B. and Molinoff, P.B. (1981) Pharmacological manipulation of β-adrenergic receptor
subtype density in rat striatum and cerebellum. Eighth International Congress of Pharmacology. Tokyo, Japan.
11. Rinard, G.A., Jensen, A.D., Puckett, A.M., Torphy, T.J., Minneman, K.P. and Mayer, S.E. (1983) Depressed β-
adrenergic response (cyclic AMP, protein kinase, relaxation) and receptor density in tracheal smooth muscle of allergic-
asthmatic dogs. Fifth International Conference on Cyclic Nucleotides and Protein Phosphorylation. Milan, Italy.
12. Minneman, K.P. and Abel, P.W. (1984) Binding and functional properties of α1-adrenergic receptors in rat caudal
artery. Fed. Proc. 43: 399.
13. Abel, P.W., Johnson, R.D., Martin, J.J. and Minneman, K.P. (1984) Effect of surgical denervation on α1-adrenergic
receptors in rat vas deferens. Fed. Proc. 43: 15.
14. May, J.M., Abel, P.W. and Minneman, K.P. (1984) Characterization of a homogeneous population of β2-adrenergic
receptors in rat vas deferens: Radioligand binding and functional response. Fed. Proc. 43: 2684.
15. Sutin, J. and Minneman, K.P. (1984) Adrenergic receptor regulation in hyperinnervated neurons. Neuroscience
Abstracts in press.
16. Abel, P.W. and Minneman, K.P. (1984) α1-Adrenoceptor density and contractile responses of rat vas deferens. The
Pharmacologist 26: 450.
17. Juberg, E.N., Minneman, K.P. and Abel, P.W. (1984) β1- and β2-adrenoceptor binding and function in rat atria. The
18. May, J.M., Abel, P.W. and Minneman, K.P. (1985) Regulation of β2-adrenergic receptors in rat vas deferens. Fed.
Proc. 44: 8309.
19. Puckett, A.M., Rinard, G.A., Jensen, A.D., Minneman, K.P., Torphy, T.J. and Mayer, S.E. (1985) Variation in β-
adrenergic-cholinergic sensitivity balance and imbalance in the trachealis smooth muscle of greyhound dogs. Fed.
Proc. 44: 261.
20. Rinard, G.A., Minneman, K.P., Torphy, T.J., Puckett, A.M., Jensen, A.D. and Mayer, S.E. (1985) Variation in β-
adrenergic receptor density determines relaxation and protein kinase activation in airway smooth muscle. Fed. Proc.
44: 262.
21. Nasseri, A., Barakeh, J.F., Abel, P.W. and Minneman, K.P. (1985) Chronic reserpine treatment and α1-adrenergic
receptors in smooth muscle. The Pharmacologist 27: 244.
22. Bazil, C.W. and Minneman, K.P. (1985) Pharmacological properties of adenosine receptors increasing cyclic AMP
accumulation in rat cerebral cortex. The Pharmacologist 27: 580.
23. May, J.M., Abel, P.W. and Minneman, K.P. (1985) Spare β-adrenergic receptors and agonist potencies in rat vas
Abstracts (continued)

deferens. The Pharmacologist 27: 246.
24. Johnson, R.D. and Minneman, K.P. (1985) α- and β-adrenergic components of norepinephrine stimulated cyclic AMP
accumulation in rat cerebral cortex. The Pharmacologist 27: 697.
25. Abel, P.W. and Minneman, K.P. (1985) Prolonged norepinephrine exposure and α1-adrenergic receptors in rat vas
deferens and caudal artery. The Pharmacologist 27: 502.
26. Johnson, R.D. and Minneman, K.P. (1985) α1-Adrenoceptors and 3
H-inositol metabolism in the rat brain. In
"Pharmacology of Adrenoceptors" ed. E. Szabadi, C.M. Bradshaw and N.R. Nahorski, Macmillan, London 303-304.
27. Johnson, R.D. and Minneman, K.P. (1985) α1-Adrenergic receptors mediating phosphatidylinositol metabolism and
cyclic AMP accumulation in the rat cerebral cortex. J. Clin. Pharmacol. 25: 632.
28. Minneman, K.P., May, J.M. and Abel, P.W. (1986) Comparison of binding and functional properties of adrenergic
receptor subtypes in smooth muscle. Smooth Muscle Function Symposium. Banff, Alberta.
29. Minneman, K.P. and Johnson, R.D. (1986) α1-Adrenergic receptors linked to inositol phosphate and cyclic AMP
accumulation in rat brain. European Soc. for Neurochemistry. Prague, Czechoslovakia.
30. Bazil, C.W., Raux, M.E. and Minneman, K.P. (1986) An in vitro method for studying effects of volatile anesthetics on
synaptic neurochemistry. Neuroscience Abstracts 12: 197.15.
31. Han, C., Abel, P.W. and Minneman, K.P. (1987) Subtypes of α1-adrenergic receptors distinguished by selective
inactivation with chlorethylclonidine. 6th International Catecholamine Symposium, Jerusalem, Israel.
32. Han, C., Abel, P.W. and Minneman, K.P. (1987) Subtypes of α1-adrenergic receptors distinguished by competitive
antagonists. 6th International Catecholamine Symposium, Jerusalem, Israel.
33. Bazil, C.W., Nasseri, A. and Minneman, K.P. (1987) Effects of halothane on noradrenergic synapses in rat cerebral
cortex. 6th International Catecholamine Symposium, Jerusalem, Israel.
34. Nasseri, A., Stein, E. and Minneman, K.P. (1987) α2-Adrenergic receptor binding sites and inhibition of norepinephrine
release. The Pharmacologist 29: 313.
35. Bazil, C.W. and Minneman, K.P. (1987) Effects of halothane on central cholinergic synapses. Neuroscience Abstracts.
36. Han, C., Minneman, K.P. and Abel, P.W. (1987) Effects of neuropeptide Y on contraction, relaxation and cyclic AMP
accumulation in rat spleen. Georgia Heart Association Symposium on Cardiovascular Research, Athens, Georgia.
37. Minneman, K.P., Han, C. and Abel, P.W. (1988) α1-Adrenergic receptor subtypes and soruces of cell Calcium.
American Society for Neurochemistry, New Orleans, Louisiana.
38. Han, C. and Minneman, K.P. (1989) Co-existence of α1a- and α1b-adrenergic receptor subtypes in rat heart. Georgia
Heart Assn. Symposium Cardiovascular Research, Athens, GA.
39. Minneman, K.P., Han, C. and Wilson, K.M. (1990) Different 3
H-inositol phosphates produced by stimulation of α1a
and α1b adrenergic receptors. FASEB J. 4: A4943.
40. Wilson, K.M. and Minneman, K.P. (1990) Pertussis toxin inhibits norepinephrine stimulated 3
H-inositol phosphate
accumulation in primary neuronal and glial cultures. FASEB J. 4: A4944.
41. Mante, S. and Minneman, K.P. (1990) A pharmacologically specific action of caffeine on forskolin stimulated cyclic
AMP accumulation in rat brain. FASEB J. 4: A4230.
42. Atkinson, B. and Minneman, K.P. (1990) Multiple adrenergic receptor subtypes involved in cyclic AMP responses to
norepinephrine in slices and cultures of rat brain. FASEB J. 4: A1961.
43. Han, C. and Minneman, K.P. (1991) Characterization of α1-adrenergic receptor subtypes in DDT1-MF2 and BC3H1
Cell Lines. FASEB J. 5: 699.
44. Minneman, K.P. and Han, C. (1991) Interaction of subtype-selective antagonists with α1-adrenergic receptor binding
sites in rat tissues. FASEB J. 5: 2819.
45. Atkinson, B.A. and Minneman, K.P. (1991) Selective alkylation of adrenergic receptor subtypes in primary glial cell
cultres. FASEB J. 5: 4884.
46. Wigginton, S.A. and Minneman, K.P. (1991) Calcium activated inositol phosphate formation in primary glial cell
cultures. FASEB J. 5: 632.
47. Esbenshade, T.A. and Minneman, K.P. (1991) Coexistence of adrenergic receptor subclasses in the human SK-N-MC
neuroepithelioma cell line. The Pharmacologist 33: 513.
48. Atkinson, B.A. and Minneman, K.P. (1991) Chronic agonist exposure and adrenergic-receptor mediated cAMP
responses in primary glial cultures. The Pharmacologist 33: 516.

49. Minneman, K.P., Esbenshade, T.A. and Han, C. (1992) Subtypes of α-adrenoceptors in contraction of smooth muscle.
"Smooth muscle" International Symposium. Fukuoka, Japan.
50. Esbenshade, T.A. and Minneman, K.P. (1992) α1-Adrenergic receptor subtypes and signal transduction in SK-N-MC
cells. FASEB J. 6: 3581.
51. Zhong, H. and Minneman, K.P. (1992) Studies of β1- and β2-adrenergic receptors co-existing in C6 glioma cells The
52. Esbenshade, T.A., Han, C., Theroux, T.L. and Minneman, K.P. (1992) Coexistence of β1-and atypical B-adrenergic
receptors coupled to cAMP formation in SK-N-MC cells. The Pharmacologist 34: 313.
53. Bandlish, R.K., Dennison, S., Esbenshade, T.A. and Minneman, K.P. (1992) Comparison of desensitization of co-
existing β1- and atypical β-adrenergic receptors in SK-N-MC cells. The Pharmacologist 34: 312.
54. Minneman, K.P., Esbenshade, T.A. and Zhong, H. (1993) Multiple receptors for noradrenaline: Opposing redundant
and synergistic interactions. Biochem. Soc. Meeting, Sheffield, England.
55. Zhong, H. and Minneman, K.P. (1993) Dexamethasone alters subtype ratio without changing total β-adrenergic
receptor density in C6 glioma cells. Neurosci. Abstracts 19: 207-209.
56. Minneman, K.P., Han, C. and Hollinger, S. (1994) Binding of 3
H - transulasin to α1-adrenergic receptor subtypes.
Societé Internationale d'Urologie 23rd
Congress, Sydney, Australia.
57. Zhong, H., Wood, S. and Minneman, K.P. (1994) Modulation of β-adrenergic receptor subtypes with inducible sense
and antisense vectors in C6 glioma cells. Pharmacology of Adrenoceptors, Philadelphia, PA.
58. Wood, S., Zhong, H. and Minneman, K.P. (1994) Selective desensitization of β-adrenergic receptor subtypes in C6
glioma cells: Effects of changing subtype ratios on catecholamine responsiveness. Pharmacology of Adrenoceptors,
Philadelphia, PA.
59. Theroux, T.L., Esbenshade, T.A. and Minneman, K.P. (1994) α1B-Adrenergic receptors are coupled to voltage-
dependent calcium influx in rMTC 6-23 cells. Pharmacology of Adrenoceptors, Phildelphia, PA.
60. Esbenshade, T.A., Zhong, H.Y. and Minneman, K.P. (1995) Inducible expression of adrenergic receptors in continuous
cell lines: Effect of receptor density on response. ASBMB, San Francisco, CA.
61. McCullough, J.R., Aberg, G., Smith, E.R. and Minneman, K.P. (1995) The binding of doxazosin and its enantiomers
to α1-adrenoceptor subtypes. ASBMB, San Francisco, CA.
62. Minneman, K.P., Wang, X., Williams, N.G. and Esbenshade, T.A. (1995) Inducible expression of α1B-adrenergic
receptors in DDT1-MF2 cells: Comparison of receptor density and response. FASEB J. 9: 603.
63. Theroux, T.L., Minneman, K.P., Hollinger, S., Han, C. and Esbenshade, T.A. (1995) Selectivity of agonists for
cloned α1-adrenergic receptor subtypes. FASEB J. 9: 604.
64. Esbenshade, T.A., Hirasawa, A., Tusjimoto, G., Tanaka, T., Yano, J., Minneman, K.P. and Murphy, T.J. (1995)
Cloning of the human α1D-adrenergic receptor and inducible expression of three human subtypes in SKNMC cells.
FASEB J. 9: 606.
65. Zhong, H., Wood, S., Esbenshade, T.A., and Minneman, K.P. (1995) Differential modulation of catecholamine
responsiveness by β1- and β2-adrenergic receptors in rat C6 glioma cells. FASEB J. 9: 3920.
66. Minneman, K.P., Theroux, T.L., and Esbenshade, T.A. (1995) α1-Adrenergic receptor subtypes and signal transduction.
10th Camerino-Noordwijkerhout Symposium, Camerino, Italy.
67. Esbenshade, T.A. and Minneman, K.P. (1995) Inducible expression of human α1-adrenergic receptor subtypes in
SKNMC cells reveals subtype-dependent differences in signaling mechanisms. 9th International Conference on Second
Messengers and Phosphoproteins, Nashville, TN.
68. Zhong, H., Williams, N.G. and Minneman, K.P. (1998) Effects of α1-, α2-, and β-adrenergic receptors on MAP kinase
activation and differentiation in transfected PC12 cells. FASEB J. 12: 2634.
69. Berts, A., Zhong, H., and Minneman, K.P. (1998) Role of Ca2+
in MAP kinase activation by α1A-adrenergic receptors
expressed in PC12 cells. FASEB J. 12: 2531.
70. Zhong, H. and Minneman, K.P. (1999) Differential activation of mitogen-activated protein kinase pathways in PC12
cells by closely-related α1-adrenergic receptor subtypes. FASEB J. 13: 2323.
71. Romeo, G., Aiello, A., Russo, F., Nicoletti, F., and Minneman, K.P. (1999) Ligands for the α1-adrenoceptor subtype.
Novel pyrimido[5,4-B]indol-2,4-dione derivatives. Medicinal Chemistry Symposium, Taormina, Italy.
72. Romeo, G., Russo, F., and Minneman, K.P. (1999) Synthesis of new pyrimido[5,4-b]indol-4-ones as potential ligands
for the α1-adrenoceptor subtypes. Medicinal Chemistry Symposium, Taormina, Italy.

73. Vicentic, A., Robeva, A.S. and Minneman, K.P. (2000) Epitope tagged α1-adrenergic receptors in PC12 cells:
Pharmacology, signaling, and biochemistry. FASEB J. 14: A1316.
74. Vicentic, A., Robeva, A. and Minneman, K.P. (2000) Immunoprecipitation of epitope-tagged α1-adrenergic receptors in
PC12 and HEK 293 cells. Soc. Neurosci. Abstracts 26: 114.
75. Romeo, G., Materia, L., Russo, F., and Minneman, K.P. (2000) Synthesis of hexahydropyrazino [2,1c][1,4]
benzoxazine derivatives as conformationally hindered analogues of N-(2-methoxyphenyl) piperazine-based α1-
adrenoceptor ligands. XVI Medicinal Chemistry Symposium, Bologna, Italy.
76. Uberti, M. and Minneman, K.P. (2001) Co-immunoprecipitation of epitope-tagged α1-adrenoceptors in HEK 293 cells.
FASEB J. 15: A564.
77. Pupo, A. and Minneman, K.P. (2001) Interaction between neuronal nitric oxide synthase (nNOS) and α1-adrenoceptor
subtypes. FASEB J. 15: A564.
78. Romeo, G., Materia, L., Russo, F., and Minneman, K.P. (2001) Synthesis of 1,2,3,9-Tetrahydro-4H-carbazol-4-one
Derivatives as Ligands for the α1-Adrenoceptor Subtypes. Hungarian-German-Italian-Polish Joint Meeting on Medicinal
Chemistry, Budapest.
79. Uberti, M. and Minneman, K.P. (2002) Dimerization of epitope tagged α1 adrenoceptors in HEK 293 cells. FASEB J.
16: A196.
80. Pupo, A.S. and Minneman, K.P. (2002) Interactions between human α1-adrenoceptor subtypes and gC1qR. FASEB J.
16: A564.
81. Pupo, A.S. and Minneman, K.P. (2002) Increased binding site density after N-terminal truncation of human α1D-
adrenergic receptors. FASEB J. 16: A565.
82. Uberti, M., Pupo, A.S., and Minneman, K.P. (2002) Co-immunoprecipitation of amino and carboxy-terminal truncated
α1-AR subtypes. The Pharmacologist 44: 110.12.
83. Chen, Z. and Minneman, K.P. (2002) Characterization of C-terminal truncated α1-adrenergic receptor subtypes. The
Pharmacologist 44: 110.11.
84. Hague, C., Pupo, A.S. and Minneman, K.P. (2003) N-terminal chimeras of the human α1-adrenergic receptor (AR)
subtypes: Investigating the role of the α1-AR N-terminus in regulating binding site expression. FASEB J. 17: A212.
85. Chen, Z., Hague, C., Alewood, D., Lewis, R., and Minneman, K.P. (2004) Differential interactions of conopeptide ρ-
TIA with human α1-adrenergic receptor (AR) subtypes. FASEB J. 18: B154.
86. Hague, C., Uberti, M.A., Chen, Z., Hall, R.A., and Minneman, K.P. (2004) Heterodimerization with α1B-adrenergic
receptors controls α1D-adrenergic receptor trafficking to the cell surface. FASEB J. 18: B156.
87. Romeo, G., Materia, L., Pittala, V., Maria, M., Russo, F. and Minneman, K.P. (2004) Ligandi per le sottoclassi del
recettore α1-adrenergico. Nuovi derivati benzotieno[3,2-d]pirimidin-(1H, 3H)2,4-dionici-8-sostituiti. XVII National
Meeting of the Medicinal Chemistry Division of the Italian Chemical Society, Pisa, Italy.
88. Lewis, R.J., Sharpe, I., Dutertre, S., Chen, Z., and Minneman, K. (2004) Discovery and characterization of ρ-
conopepties: Novel inhibitors of α1-adrenoceptors. International Society for Heart Research, Brisbane, Australia.
89. Hague, C., Uberti, M.A., Chen, Z., Bush, C.F., Jones, S.V., Ressler, K.J., Hall, R.A., and Minneman, K.P. (2005)
Olfactory and β2-adrenergic receptors form stable cell-surface complexes. FASEB J. 258.
90. Bernstein, L.S., Hague, C., Ramineni, S., Chen, Z., Minneman, K.P. and Hepler, J.R. (2005) RGS2 is selectively
recruited by α1A-adrenergic receptors to form a stable functional complex. FASEB J. 259.
91. Hague, C., Lee, S., Prinster, S.C., Chen, Z.J., Hall, R.A., and Minneman, K.P. (2006) Heterodimers of α1B and α1D-
adrenergic receptors form a single functional entity. FASEB J. A253.
92. D. E. Croker, I.A. Sharpe, E. Palant, P. F. Alewood, Z. Chen, G. Rogge, C. Hague, B. Colless, K.P. Minneman and R.J. Lewis.
(2006) α1-adrenoceptor antagonism by the conopeptide ρ-TIA. IUPHAR Meeting, Beijing, China.
93. Salerno, L., Materia, L., Marucci, G., Modica, M., Pittalà, V., Siracusa, M. A., Buccioni, M., Angeli, P., Romeo, G., and
Minneman, K. P. (2006) Novel arylpiperazine ligands with high affinity for the α1-adrenergic receptor subtypes. XXII National
Congress of the Italian Chemical Society, Florence, Italy

Minneman CV

Recommended

Recommended

More Related Content

What's hot

What's hot (12)

Viewers also liked

Viewers also liked (13)

Similar to Minneman CV

Similar to Minneman CV (20)

Minneman CV